经直肠超声联合超声造影评估宫颈癌局部浸润的诊断效能
回顾性纳入69例宫颈癌患者,评估经直肠超声(TR-US)联合经直肠超声造影(TR-CEUS)对比MRI与组织病理学评估宫颈癌局部浸润的诊断效能,并验证「边缘征」作为排除宫旁浸润的生物标志物。结果显示TR-CEUS提高测量信度,联合方案与MRI诊断一致性 comparable,边缘征排除宫旁浸润特异度95.8%、阴性预测值92.0%。
要点
- TR-US联合TR-CEUS评估宫旁浸润与组织病理学(κ=0.672)及MRI(κ=0.789)一致性良好。
- 「边缘征」排除宫旁浸润特异度95.8%、阴性预测值92.0%。
- TR-CEUS提高肿瘤测量信度(ICC=0.751至0.784),与MRI精度相当(ICC=0.804 vs 组织病理学)。
核心结论
- TR-US/TR-CEUS诊断准确性与MRI相当,并提高观察者一致性;「边缘征」作为高特异度生物标志物用于术前排除宫旁浸润,提供较MRI经济的替代选择。
研究设计与样本
- 回顾性研究纳入69例宫颈癌患者(54例手术、15例接受新辅助治疗),行TR-US、TR-CEUS及MRI检查,以组织病理学为参考标准评估肿瘤尺寸、阴道/宫旁浸润及「边缘征」。
关键影像表现/征象
- 「边缘征」为TR-CEUS上用于排除宫旁浸润的影像征象,原文未描述其具体信号或回声特点。
诊断标准与关键数值
- 「边缘征」排除宫旁浸润:特异度95.8%,阴性预测值92.0%。
- TR-CEUS测量肿瘤与组织病理学ICC=0.804,与MRI精度相当。
- TR-US/TR-CEUS评估阴道浸润观察者间κ=0.621至0.694,评估宫旁浸润κ=0.579至0.678。
- TR-US/TR-CEUS评估宫旁浸润与组织病理学κ=0.672、与MRI κ=0.789;TR-US单独分别为κ=0.563和κ=0.679。
临床应用与阅片要点
- 作者认为TR-US/TR-CEUS诊断准确性可比MRI,可作为较MRI经济的替代选择。
- 作者认为「边缘征」可作为术前排除宫旁浸润的高特异度生物标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the diagnostic performance of transrectal ultrasound (TR-US) combined with contrast-enhanced TR-US (TR-CEUS) against MRI and histopathology for assessing cervical cancer local invasion, and to validate the "rim sign" as a biomarker for parametrial exclusion.
METHODS: A retrospective study of 69 cervical cancer patients (54 surgical, 15 neoadjuvant therapy recipients) undergoing TR-US, TR-CEUS, and MRI was conducted. Tumour dimensions, vaginal/parametrial invasion, and the "rim sign" were evaluated. Diagnostic agreement was assessed using intraclass correlation coefficients (ICC) and Cohen' s κ, while the specificity and negative predictive value (NPV) of the "rim sign" were calculated.
RESULTS: TR-CEUS improved TR-US reliability in tumour measurement (ICC = 0.751 to 0.784), achieving MRI-comparable accuracy (ICC = 0.804 vs. histopathology). Combined TR-US/TR-CEUS enhanced interobserver consistency for vaginal infiltration (κ = 0.621 to 0.694) and parametrial invasion (κ = 0.579 to 0.678) compared to TR-US alone. TR-US/TR-CEUS showed good agreement with histopathology (κ = 0.672) and MRI (κ = 0.789) for parametrial assessment than TR-US (κ = 0.563/0.679). The "rim sign" demonstrated 95.8% specificity and 92.0% NPV for parametrial exclusion.
CONCLUSIONS: TR-US/TR-CEUS achieves diagnostic accuracy comparable to MRI while improving observer consistency. The "rim sign" serves as a high-specificity biomarker for preoperative parametrial exclusion, offering a cost-effective alternative to MRI.
ADVANCES IN KNOWLEDGE: This study provides quantitative evidence of TR-CEUS improving diagnostic reproducibility for cervical cancer invasion. The "rim sign" is identified as a novel imaging biomarker with high specificity for parametrial preservation.
引用
- Zhang J, Jin LF, Jia C, et al. Assessing local invasion in cervical cancer: the diagnostic performance of transrectal contrast-enhanced ultrasonography. Br J Radiol. 2026. PMID: 41259003. doi:10.1093/bjr/tqaf283
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。